Pear Therapeutics, Inc. Profile
Industry
Medical - Healthcare Information ServicesSector
HealthcareNumber of Employees
200Pear rapeutics's Business Model
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
About Pear rapeutics
Website: https://peartherapeutics.com
CEO (Chief Executive Officer): Mr. Christopher D. T. Guiffre J.D., M.B.A., MBA
IPO date: 2021-03-31
Contact
Country: US
Address: 200 State Street
City: Boston
State: MA
Phone: 617 925 7848
Zip Code: 02109
Other
CIK: 0001835567
ISIN: US7047231052
CUSIP: 704723105
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
